Key result
Urolithin A attenuates AHR-mediated inflammatory signaling in vitro as a direct human-selective antagonist.
Why the study?
The molecular mechanisms underlying the beneficial effects of urolithins, including their anti-inflammatory and anti-cancer effects, remain unclear.
Urolithin A is identified as a dietary microbiota-derived human selective AHR antagonist, providing a molecular mechanism for its anti-inflammatory effects.
Answers are grounded in this paper and cite their sources.
May inform AHR-targeted anti-inflammatory strategies; leaves open translation to human cardiovascular disease.
Urolithins (e.g., UroA and B) are gut microbiota-derived metabolites of the natural polyphenol ellagic acid. Urolithins are associated with various health benefits, including attenuation of inflammatory signaling, anti-cancer effects and repression of lipid accumulation. The molecular mechanisms underlying the beneficial effects of urolithins remain unclear. We hypothesize that some of the human health benefits of urolithins are mediated through the aryl hydrocarbon receptor (AHR). Utilizing a cell-based reporter system, we tested urolithins for the capacity to modulate AHR activity. Cytochrome P450 1A1 (CYP1A1) mRNA levels were assessed by real-time quantitative polymerase chain reaction. Competitive ligand binding assays were performed to determine whether UroA is a direct ligand for the AHR. Subcellular AHR protein levels were examined utilizing immunoblotting analysis. AHR expression was repressed in Caco-2 cells by siRNA transfection to investigate AHR-dependency. UroA and B were able to antagonize 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced AHR-mediated transcriptional activity. Furthermore, UroA and B attenuated TCDD-mediated stimulation of CYP1A1 mRNA levels. In addition, competitive ligand binding assays characterized UroA as a direct AHR ligand. Consistent with other AHR antagonists, UroA failed to induce AHR retention in the nucleus. AHR is necessary for UroA-mediated attenuation of cytokine-induced interleukin 6 (IL6) and prostaglandin-endoperoxide synthase 2 (PTGS2) expression in Caco-2 cells. Here we identified UroA as the first dietary-derived human selective AHR antagonist produced by the gut microbiota through multi-step metabolism. Furthermore, previously reported anti-inflammatory activity of UroA may at least in part be mediated through AHR.
No takes yet. Share an insight, caveat, or question.
Muku et al. (2018) studied this question. Urolithin A vs. Vehicle or TCDD alone was evaluated on AHR-mediated transcriptional activity and CYP1A1 mRNA levels (p=<0.0001). Urolithin A acts as a direct, human-selective aryl hydrocarbon receptor antagonist that attenuates TCDD-induced AHR-mediated transcriptional activity and inflammatory signaling in vitro.
Synapse has enriched 10 related papers. Consider them for comparative context: